Oramed Pharmaceuticals Inc (ORMP)
2.25
+0.05
(+2.27%)
USD |
NASDAQ |
Apr 19, 16:00
2.25
0.00 (0.00%)
After-Hours: 17:34
Oramed Pharmaceuticals Accounts Receivable (Quarterly)
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2013 | 0.3337M |
| February 28, 2013 | 0.4398M |
| November 30, 2012 | 0.076M |
| August 31, 2012 | |
| May 31, 2012 | 0.1354M |
| February 29, 2012 | 0.0467M |
| November 30, 2011 | 0.086M |
| August 31, 2011 | 0.5429M |
| Date | Value |
|---|---|
| May 31, 2011 | 0.5622M |
| February 28, 2011 | 0.0874M |
| November 30, 2010 | 0.0238M |
| August 31, 2010 | 0.0592M |
| May 31, 2010 | 0.0356M |
| February 28, 2010 | 0.0341M |
| November 30, 2009 | 0.0342M |
| August 31, 2009 | 0.0369M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Receivable (Quarterly) Benchmarks
| Inogen Inc | 42.24M |
| Petros Pharmaceuticals Inc | 2.226M |
| DIH Holding US Inc | -- |
| NovaBay Pharmaceuticals Inc | 0.759M |
| Palatin Technologies Inc | 2.346M |